1
|
Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer.
|
J Clin Oncol
|
2001
|
4.97
|
2
|
Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety data.
|
J Clin Oncol
|
2001
|
1.58
|
3
|
Costimulatory signals can selectively modulate cytokine production by subsets of CD4+ T cells.
|
J Immunol
|
1995
|
0.82
|
4
|
Penicillin allergy.
|
West J Med
|
1991
|
0.75
|
5
|
No 'sterile cockpits,' please.
|
Am J Nurs
|
1994
|
0.75
|
6
|
Pharmacy: four/three for staffing satellites.
|
Hospitals
|
1974
|
0.75
|
7
|
Improving control drug distribution through nursing--pharmacy cooperation.
|
Hosp Top
|
1977
|
0.75
|